Pacira BioSciences
PCRX
PCRX
239 hedge funds and large institutions have $980M invested in Pacira BioSciences in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 90 increasing their positions, 82 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 260 → 239 (-21)
19% less capital invested
Capital invested by funds: $1.21B → $980M (-$235M)
33% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 45
Holders
239
Holding in Top 10
4
Calls
$477K
Puts
$296K
Top Buyers
| 1 | +$6.15M | |
| 2 | +$5.99M | |
| 3 | +$4.44M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$4.38M |
| 5 |
BCC
Bridge City Capital
Lake Oswego,
Oregon
|
+$2.61M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$11.3M | |
| 3 | -$11.1M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$7.86M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$7.54M |
